Astrazeneca (AZN) is a Top Dividend Stock Right Now: Should You Buy?Zacks Investment Research • 04/17/23
New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapyPRNewsWire • 04/14/23
AstraZeneca reinforces commitment to advancing science for patients with chronic kidney disease and hyperkalemia at NKF Spring Clinical Meeting 2023Business Wire • 04/11/23
Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian CancerInvestors Business Daily • 04/05/23
Compass Group and AstraZeneca Expand Activities Focused on Innovation and Shared SuccessBusiness Wire • 03/29/23
3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030The Motley Fool • 03/23/23
Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV RaceInvestors Business Daily • 03/08/23
Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease AssayBusiness Wire • 03/07/23